Efficacy and Pharmacodynamic Study of Panzem® NCD in Patients With Hormone-Refractory Prostate Cancer
Clinical trial NCT00394810 · COMPLETED
Trial details
- NCT number
- NCT00394810
- Sponsor
- CASI pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Primary completion
- 2008-11-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.